CIK 0000711377
- Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 382367843
- Phone
- +1 517-372-9200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-27 | ADENT JOHN EDWARD Former CEO | Exercise or conversion | +38,759 | $6.19 | $240K | 371,608 |
| 2025-10-27 | ADENT JOHN EDWARD Former CEO | Shares withheld for taxes | −8,527 | $6.19 | $53K | 363,081 |
| 2025-10-27 | ADENT JOHN EDWARD Former CEO | Exercise or conversion · Restricted Stock Units | −38,759 | $6.19 | $240K | 38,759 |
| 2025-10-13 | ADENT JOHN EDWARD Former CEO | Exercise or conversion | +3,063 | $6.04 | $19K | 333,714 |
| 2025-10-13 | ADENT JOHN EDWARD Former CEO | Shares withheld for taxes | −865 | $6.04 | $5K | 332,849 |
| 2025-10-13 | ADENT JOHN EDWARD Former CEO | Exercise or conversion · Restricted Stock Units | −3,063 | $6.04 | $19K | 3,063 |
| 2025-10-07 | ADENT JOHN EDWARD Former CEO | Exercise or conversion | +32,936 | $5.63 | $185K | 339,948 |
| 2025-10-07 | ADENT JOHN EDWARD Former CEO | Shares withheld for taxes | −9,297 | $5.63 | $52K | 330,651 |
| 2025-10-07 | ADENT JOHN EDWARD Former CEO | Exercise or conversion · Restricted Stock Units | −32,936 | $5.63 | $185K | 0 |
| 2025-08-18 | ADENT JOHN EDWARD CEO | Exercise or conversion | +35,736 | $5.43 | $194K | 307,012 |
| 2025-08-18 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −35,736 | $5.43 | $194K | 71,472 |
| 2025-04-28 | ADENT JOHN EDWARD CEO | Exercise or conversion | +2,112 | $5.16 | $11K | 271,276 |
| 2025-04-28 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −2,112 | $5.16 | $11K | 4,224 |
| 2025-01-16 | ADENT JOHN EDWARD CEO | Purchase | +23,035 | $11.03 | $254K | 269,164 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Exercise or conversion | +38,760 | $13.81 | $535K | 257,409 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Shares withheld for taxes | −11,280 | $13.81 | $156K | 246,129 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −38,760 | $13.81 | $535K | 77,520 |
| 2024-10-14 | ADENT JOHN EDWARD CEO | Exercise or conversion | +3,064 | $14.43 | $44K | 219,541 |
| 2024-10-14 | ADENT JOHN EDWARD CEO | Shares withheld for taxes | −892 | $14.43 | $13K | 218,649 |
| 2024-10-14 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −3,064 | $14.43 | $44K | 6,127 |
Page 1 of 4 · 62 trades